Curable composition and cured composition prepared therefrom

US11919989B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11919989-B2
Application numberUS-202117165228-A
CountryUS
Kind codeB2
Filing dateFeb 2, 2021
Priority dateFeb 28, 2020
Publication dateMar 5, 2024
Grant dateMar 5, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A curable composition includes a functionalized phenylene ether oligomer, a reactive diluent, and a photoinitiator. The curable composition can be cured to provide a cured composition. Articles comprising the cured composition and methods for the manufacture of the cured composition are also described. The curable composition can be particularly useful for providing three-dimensional, additively-manufactured articles.

First claim

Opening claim text (preview).

What is claimed is: 1. A curable composition comprising: 20 to 40 weight percent of a functionalized phenylene ether oligomer having an intrinsic viscosity of 0.03 to 0.13 deciliter per gram, measured at 25° C. in chloroform using an Ubbelohde viscometer; 60 to 80 weight percent of a reactive diluent, wherein the reactive diluent is a (meth)acrylate-containing monomer; and a photoinitiator; wherein weight percent is based on the total weight of the phenylene ether oligomer and the reactive diluent; and wherein the functionalized phenylene ether oligomer has the structure wherein Q 1 and Q 2 each independently comprise halogen, unsubstituted or substituted C 1-12 primary or secondary hydrocarbyl, C 1-12 hydrocarbylthio, C 1-12 hydrocarbyloxy, and C 2-12 halohydrocarbyloxy wherein at least two carbon atoms separate the halogen and oxygen atoms; Q 3 and Q 4 each independently comprise hydrogen, halogen, unsubstituted or substituted C 1-12 primary or secondary hydrocarbyl, C 1-12 hydrocarbylthio, C 1-12 hydrocarbyloxy, and C 2-12 halohydrocarbyloxy wherein at least two carbon atoms separate the halogen and oxygen atoms; Z is independently at each occurrence a (meth)acrylate group, a vinyl benzene group, an allyl group, or a maleimide group; and L is of the structure wherein R 3 , R 4 , R 5 , and R 6 each independently comprise hydrogen, halogen, unsubstituted or substituted C 1-12 primary or secondary hydrocarbyl, C 1-12 hydrocarbylthio, C 1-12 hydrocarbyloxy, and C 2-12 halohydrocarbyloxy wherein at least two carbon atoms separate the halogen and oxygen atoms; z is 0 or 1; and Y has a structure wherein R 7 is independently at each occurrence hydrogen and C 1-12 hydrocarbyl; R 8 and R 9 are independently at each occurrence hydrogen, C 1-12 hydrocarbyl, and C 1-6 hydrocarbylene wherein R 8 and R 9 collectively form a C 4-12 alkylene group; R 10 is independently at each occurrence a C 1-6 hydrocarbylene group; R 11 is independently at each occurrence a hydrogen, C 1-12 hydrocarbyl or C 1-12 halohydrocarbyl; and n is 5 to 50; and x and y are independently 0 to 30, provided that the sum of x and y is at least 2. 2. The curable composition of claim 1 , wherein Q 1 and Q 2 each independently comprise unsubstituted or substituted C 1-12 primary or secondary hydrocarbyl; Q 3 and Q 4 each independently comprise hydrogen; Z is a (meth)acrylate group; and L is of the structure wherein R 3 , R 4 , R 5 , and R 6 each independently comprise hydrogen or unsubstituted or substituted C 1-12 primary or secondary hydrocarbyl; and z is 1. 3. The curable composition of claim 1 , wherein L is wherein n is 5 to 45. 4. The curable composition of claim 1 , wherein the reactive diluent comprises a C 1-24 alkyl (meth)acrylate monomer, a di(meth)acrylate) comprising dipropylene glycol diacrylate, hexanediol diacrylate, tripropylene glycol diacrylate, isobornyl acrylate, isobornyl methacrylate, 4-t-butylcyclohexyl acrylate, or a combination thereof, or a combination thereof. 5. A curable composition comprising: 5 to 30 weight percent of a functionalized phenylene ether oligomer having an intrinsic viscosity of 0.03 to 0.13 deciliter per gram, measured at 25° C. in chloroform using an Ubbelohde viscometer; 17 to 37 weight percent of a reactive diluent, wherein the reactive diluent is a (meth)acrylate-containing monomer; 57 to 73 weight percent of a photocurable resin; and a photoinitiator; wherein weight percent is based on the total weight of the phenylene ether oligomer, the reactive diluent and the photocurable resin; and wherein the functionalized phenylene ether oligomer has the structure wherein Q 1 and Q 2 each independently comprise halogen, unsubstituted or substituted C 1-12 primary or secondary hydrocarbyl, C 1-12 hydrocarbylthio, C 1-12 hydrocarbyloxy, and C 2-12 halohydrocarbyloxy wherein at least two carbon atoms separate the halogen and oxygen atoms; Q 3 and Q 4 each independently comprise hydrogen, halogen, unsubstituted or substituted C 1-12 primary or secondary hydrocarbyl, C 1-12 hydrocarbylthio, C 1-12 hydrocarbyloxy, and C 2-12 halohydrocarbyloxy wherein at least two carbon atoms separate the halogen and oxygen atoms; Z is independently at each occurrence a (meth)acrylate group, a vinyl benzene group, an allyl group, or a maleimide group; and L is of the structure wherein R 3 , R 4 , R 5 , and R 6 each independently comprise hydrogen, halogen, unsubstituted or substituted C 1-12 primary or secondary hydrocarbyl, C 1-12 hydrocarbylthio, C 1-12 hydrocarbyloxy, and C 2-12 halohydrocarbyloxy wherein at least two carbon atoms separate the halogen and oxygen atoms; z is 0 or 1; and Y has a structure wherein R 7 is independently at each occurrence hydrogen and C 1-12 hydrocarbyl; R 8 and R 9 are independently at each occurrence hydrogen, C 1-12 hydrocarbyl, and C 1-6 hydrocarbylene wherein R 8 and R 9 collectively form a C 4-12 alkylene group; R 10 is independently at each occurrence a C 1-6 hydrocarbylene group; R 11 is independently at each occurrence a hydrogen, C 1-12 hydrocarbyl or C 1-12 halohydrocarbyl; and n is 5 to 50; and x and y are independently 0 to 30, provided that the sum of x and y is at least 2. 6. The curable composition of claim 1 , wherein the photoinitiator is a free radical photoinitiator. 7. The curable composition of claim 1 , further comprising a thermal initiator. 8. The curable composition of claim 1 , further comprising: an auxiliary resin comprising an epoxy resin, a cyanate ester resin, a maleimide resin, a benzoxazine resin, a vinylbenzyl ether resin, an arylcyclobutene resin, a perfluorovinyl ether resin, oligomers or polymers with curable vinyl functionality, or a combination thereof; and a curing promoter comprising aliphatic and cycloaliphatic amines and amine-functional adducts with epoxy resins, Mannich bases, aromatic amines, polyamides, amidoamines, phenalkamines, dicyandiamide, polycarboxylic acid-functional polyesters, carboxylic acid anhydrides, amine-formaldehyde resins, phenol-formaldehyde resins, polysulfides, polymercaptans, or a combination thereof. 9. The curable composition of claim 1 , comprising 1 to 10 parts per hundred of the photoinitiator, based on the total weight of the phenylene ether oligomer and the reactive diluent. 10. The curable composition of claim 5 , comprising 1 to 10 parts per hundred of the photoinitiator, based on the total weight of the phenylene ether oligomer, the reactive diluent and the photocurable resin. 11. A cured composition comprising a cured product of the curable composition of claim 1 , optionally wherein the cured composition has a glass transition temperature of greater th

Assignees

Inventors

Classifications

  • C08F283/08Primary

    on to polyphenylene oxides · CPC title

  • C08F283/06Primary

    on to polyethers, polyoxymethylenes or polyacetals {(C08F283/004 takes precedence)} · CPC title

  • C08G65/485Primary

    Polyphenylene oxides · CPC title

  • by ultraviolet or visible light · CPC title

  • grafted on to macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11919989B2 cover?
A curable composition includes a functionalized phenylene ether oligomer, a reactive diluent, and a photoinitiator. The curable composition can be cured to provide a cured composition. Articles comprising the cured composition and methods for the manufacture of the cured composition are also described. The curable composition can be particularly useful for providing three-dimensional, additivel…
Who is the assignee on this patent?
Shpp Global Tech Bv
What technology area does this patent fall under?
Primary CPC classification C08F283/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).